Benjamin Shepherd is a recognized exchange-traded fund (ETF), mutual fund and stock expert with an extensive background analyzing time-tested funds, including their managers and strategies. Ben looks for investments that have proven themselves in both bull and bear markets. Ben also specializes in covering emerging markets, pinpointing the most dynamic investments in developing nations for market-beating growth.
Ben is an analyst for Global Income Edge and regularly contributes to Personal Finance, Investing Daily’s flagship product.
Did you miss the first Coca-Cola? The first McDonalds? Apple’s IPO? Here’s your second chance. From Eastern Europe to the Pacific Rim to South America – new markets are buoying investor profits. These are multiple market opportunities – new industrial giants, pharmaceuticals, and high-tech. Plus moneyed new consumers with any eye to buy every gadget – from phones to refrigerators – that have long been staples in our own society. For investors, it’s a once-in-a-lifetime ground-floor opportunity to profit from the birth of new economies. Learn More
Personal Finance is your one-stop source for market-beating investing advice. Philip Springer scours the world for the best investments – whether it be a stock, bond, MLP or commodity – to build and protect your wealth no matter what the “market” does. Get in-depth insight and analysis that cuts through the noise and hype to reveal the truth about the economy, the market and your investments. In today’s challenging market, let our 39 years of proven, battle-tested experience show you the smartest path to profits. Learn More
The recent market swoon has made this company a great value.
The stock sell-off has made this money management firm a great bargain.
Stericycle has the answer to today’s health fears.
Otonomy is revolutionizing the treatment of ear infections.
Earnings will grow along with consumer confidence at this restaurant chain.
This construction company survived the recession and came out stronger than ever.
You don’t have to take on much risk to profit from cutting-edge medicine
For this health care company, regulation is a windfall.
Abercrombie and Fitch’s new strategy is looking fine.
This poultry producer is taking full advantage of soaring beef and pork prices.